Literature DB >> 24478910

Herpes zoster and diabetes mellitus.

Ivan Chernev1, Eric Gomez2.   

Abstract

Entities:  

Year:  2013        PMID: 24478910      PMCID: PMC3903810          DOI: 10.3344/kjp.2014.27.1.92

Source DB:  PubMed          Journal:  Korean J Pain        ISSN: 2005-9159


× No keyword cloud information.

LETTERS TO EDITORS

We read with interest an article by Yoon et al. published in The Korean Journal of Pain [1]. This article describes a case of disseminated herpes zoster in immunocompetent elderly patient with previous medical history of diabetes mellitus. Although disseminated herpes zoster is common in the immunocompromised patient, it is a rare clinical finding in the immunocompetent patient. The reactivation of varicella-zoster virus (VZV) occurs with the decline of VZV-specific cell-mediated immunity. Studies have shown increased incidence of herpes zoster incidence in diabetic patients [2,3]. Furthermore, Okamoto et al. compared VZV-specific immunity of patients with diabetes mellitus and healthy individuals and found that patients with diabetes mellitus had significantly lower cell-mediated immunity to VZV than did healthy individuals [4]. They suggested that the increased risk for herpes zoster among patients with diabetes mellitus may be related to decreased VZV-specific cell-mediated immunity. Although more evidence is needed to find the exact mechanism by which diabetes mellitus affects VZV-specific cell-mediated immunity, physicians should be aware that diabetes mellitus may be a condition compromising the immune competency of the patient against VZV infection.
  4 in total

1.  Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals.

Authors:  Shigefumi Okamoto; Atsuko Hata; Kay Sadaoka; Koichi Yamanishi; Yasuko Mori
Journal:  J Infect Dis       Date:  2009-11-15       Impact factor: 5.226

2.  [Herpes zoster incidence in diabetic patients].

Authors:  P Aldaz; J A Díaz; J R Loayssa; M J Dronda; M Oscáriz; J Castilla
Journal:  An Sist Sanit Navar       Date:  2013 Jan-Apr       Impact factor: 0.829

3.  Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study.

Authors:  A Hata; M Kuniyoshi; Y Ohkusa
Journal:  Infection       Date:  2011-07-29       Impact factor: 3.553

4.  Disseminated herpes zoster in an immunocompetent elderly patient.

Authors:  Keon Jung Yoon; Su Hwa Kim; Eun Ha Lee; Ji Hye Choi
Journal:  Korean J Pain       Date:  2013-04-03
  4 in total
  2 in total

Review 1.  A rare case report and appraisal of the literature on spontaneous tooth exfoliation associated with trigeminal herpes zoster.

Authors:  Rupinder Kaur; Pooja Rani; Divye Malhotra; Rajwant Kaur; Praveen Kumar Dass
Journal:  Oral Maxillofac Surg       Date:  2016-05-06

Review 2.  Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia.

Authors:  Grisuna Singh; Sejin Song; Eunjoo Choi; Pyung-Bok Lee; Francis Sahngun Nahm
Journal:  Korean J Pain       Date:  2020-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.